期刊文献+

92例咳嗽变异性哮喘患者的呼出气一氧化氮浓度与气流阻塞的相关研究 被引量:3

Association between exhaled nitric oxide and airflow obstruction in patients with cough variant asthma
原文传递
导出
摘要 目的:观察咳嗽变异性哮喘(cough variant asthma,CVA)患者的呼出气一氧化氮浓度(F E NO)变化及其与气流阻塞间的相关性。方法:2012年7月至2013年6月经支气管激发试验确诊的92例CVA成人患者,分别行常规肺功能、脉冲振荡肺功能和F E NO检测。结果:92例CVA患者中44例的F E NO>50 ppb,34例的F E NO为25~50 ppb,仅14例F E NO<25 ppb。3组患者均无显著的气流阻塞,但均有轻度外周小气道障碍。脉冲振荡肺功能测试中,所有患者的呼吸总阻抗和共振频率均略有增高,同时反映外周气道阻力的外周气道阻抗及5 Hz、20 Hz粘性阻力差值(R5-R20)也出现显著增高。结论:F E NO与气道高反应性密切相关,CVA患者的F E NO水平普遍增高,且同时合并外周气道气流阻塞。F E NO检测有助于CVA的临床诊断。 Objective: To observe the changes of fractional exhaled nitric oxide (FENO) in patients with cough variant asthma (CVA) and correlation of FENO with airflow obstruction. Methods: Ninety-two patients with bronchial provocation test confirmed CVA from July 2012 to June 2013 were enrolled. Routine lung function tests, impulse oscillometry (lOS) lung function test, and FENO test using nitric oxide analyzer (Nano Coulomb, Sunvou Biotech, Wuxi, China) were performed. Results Forty-four patients had high level of FENO (〉50 ppb), 34 patients had FENO level of 25- 50 ppb, only 14 patients had a F^NO value below 25 ppb. No significant airflow obstruction was found, but low FEF~_75 (%) predicted value was seen in all CVA patients. IOS parameters such as total respiratory impedance (Zrs), resonant frequency (Fres) were increased slightly, and peripheral resistance (Rp) and R5-R20 were increased significantly. Conclusions: There is a close association between exhaled nitric oxide and bronchial hyper-responsiveness (BHR). High FENO value and peripheral airflow obstruction are seen in CVA patients, and FENO test could be used as a diagnostic tool for CVA.
出处 《诊断学理论与实践》 2013年第5期522-525,共4页 Journal of Diagnostics Concepts & Practice
关键词 咳嗽变异性哮喘 呼出气一氧化氮 慢性咳嗽 气流阻塞 Cough variant asthma Exhaled nitric oxide Chronic cough Airflow obstruction
  • 相关文献

参考文献16

  • 1American Thoracic Society; European Respiratory Society. ATSIERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 200S [J]. Am J Respir Crit Care Med,200S, 171 (8): 912-930.
  • 2Dweik RA, Boggs PB, Erzurum SC, et al An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med,2011,184(5):602-61S.
  • 3American Thoracic Society. Lung function testing; selection of reference values and interpretative strategies: American Thoracic Society Statement[J]. Am Rev Respir Dis,1991,144 (5):1202-1218.
  • 4Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments[J]. Eur Respir J ,2003,22(6): 1026-1 041.
  • 5Nakajima T, Nishimura Y, Nishiuma T, et al. developed classic asthma during the course of cough variant asthma: a longitudinal study[J]. Respiration,200S,72 (6):606-611.
  • 6Parker Al, Abu-Hijleh M, McCool FD. Ratio between forced expiratory flow between 2S% and 7S% of vital capacity and FVC is a determinant of airway reactivity and sensitivity to methacholine[J]. Chest,2003,124(1):63-69.
  • 7Yoon JY, Woo SI, Kim H, et al. Fractional exhaled nitric oxide and forced expiratory flow between 2S% and 7S% of vital capacity in children with controlled asthma [J]. Korean J Pediatr,2012,SS(9):330-336.
  • 8Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients [J]. Lancet, 1994,343(8890): 133-13S.
  • 9Olin AC, Rosengren A, Theile DS, et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample[J]. Chest,2006,130 (S): 1319-132S.
  • 10Taylor DR, Mandhane P, Greene JM, et al. Factors affecting exhaled nitric oxide measurements: the effect of sex[J]. Respir Res,2007,8:82.

二级参考文献44

  • 1刘春涛,何权瀛.2004中国哮喘论坛专家共识[J].中国呼吸与危重监护杂志,2004,3(4):204-208. 被引量:16
  • 2刘春涛.新指南,新起点[J].中国呼吸与危重监护杂志,2003,2(1):3-13. 被引量:31
  • 3姚婉贞,赵鸣武,韩荣藓.以肺功能实测值做为支气管激发试验的判定指标比较分析[J].中华结核和呼吸杂志,1994,17(4):220-222. 被引量:3
  • 4马煜,刘传合,黄永坚.呼出气体中的一氧化氮检测与哮喘[J].中华儿科杂志,2005,43(6):421-422. 被引量:19
  • 5宇传华 徐勇勇.ROC分析的基本原理[J].中华流行病学杂志,1998,19(2):413-415.
  • 6Parker AL,Abu-Hijleh M,McCool FD.Ratio between forced expiratory flow between 25% and 75% of vital capacity and FVC is a determinant of airway reactivity and sensitivity to methacholine.Chest,2003,124:63-69.
  • 7Currie GP,Jackson CM,Lee DK,et al.Determinants of airway hyperresponsiveness in mild asthma.Ann Allergy Asthma Immunol,2003,90:560-563.
  • 8van der Lee I,Zanen P,van den Bosch JM,et al.Pattem of diffusion disturbance related to clinical diagnosis:The K(CO) has no diagnostic value next to the DL (CO).Respir Med,2006,100:101-109.
  • 9Ulrik CS,Backer V.Nonreversible airflow obstruction in lifelong nonsmokers with moderate to severe asthma.Eur Respir J,1999,14:892-896.
  • 10Hudon C,Turcotte H,Laviolette M,et al.Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction.Ann Allergy Asthma Immunol,1997,78:195-202.

共引文献72

同被引文献41

  • 1徐芳,高林善.清肺消炎丸防治肺纤维化的机理分析[J].中国执业药师,2006(8):37-37. 被引量:1
  • 2中华人民共和国卫生部.中药新药临床研究指导原则[S].中国医药科技出版社,2002:135-137.
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 4Global strategy for the Diagnosis management and prevention of COPD [J]. revised,2011:16.
  • 5Rana, G. S.J.B. ,York, T.P. ,Edmiston, J.S. ,Ze dler, Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD), Analyti- cal and bioanalytical chemistry[J]. 2010,397 (5) :241-9.
  • 6Mathers CD,Loncar D. Projections of global mortal- ity and burden of disease from 2002 to 2030[J]. PLoS Meal, 2006,3 :e442. 2010,50(27) : 107-108.
  • 7Global strategy for the Diagnosis management and prevention of COPD [J] revised ,2013 : 1.
  • 8国家中医药管理局.中医药行业标准-中医病证诊断疗效标准[s].ZY/T001.1~001.9~12.[s].中国医药科技出版社,2012:11.
  • 9Rutgers SR, Timens W , Kaufmann HF, eta1. Comparison of induced sputum with bronchial wash,bronchoal- veolar lavage and bronchial biopsies in COPD[J]. EurRespir, 2000,15:109 115.
  • 10RytilaP, Plataki M , Bucchieri F, et al. Airway neutrophiliain COPD is not associated with increased neutrophil survival[J]. EurRespir,2006,28:1163-1169.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部